Nordic Issuing

Ongoing case

Scandinavian Real Heart AB

Back to all cases

Scandinavian Real Heart AB

1 Feb - 28 Feb 2023Warrant exercise TO 1

The power of Swedish innovation has provided the world with medtech inventions such as the heart and lung machine, the pace maker and the dialysis machine. The next big innovation is Realheart’s artificial heart. A Swedish patented product that saves lives and provides a better quality of a prolonged life.

Azad Najar outlined the company’s vision in 1999 when he began designing an artificial heart that mimicked the human heart. In 2007, Azad and two business partners founded Scandinavian Real Heart.

The development of the product has advanced according to the time schedule set when the company was founded. Today, research is carried out in a close collaboration with world-leading heart surgeons, international researchers and engineers and interest from the world of research is constantly growing.

The business is run by a strong, competent and engaged team, competent and broad management team, under a strong board of directors.

Read more at the company's website

The offer in summary

Subscription period: 1 Februari - 28 Februari 2023

Price per share: SEK 2.36

Trading with warrants: 1 Februari - 24 Februari 2023

Terms: Four (4) warrants of serie TO 1 gives you the right to subscribe for one (1) new share.

Payment day: 28 Februari 2023

Market place: First North Stockholm

Financial advicer: Skills Corporate Finance



Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.